Dr. Jane Elizabeth Gilmore, MD

Dr. Gilmore practices at Ophthalmology Surgery Center of Dallas in Dallas, Texas.

Dr. Gilmore's NPI, 1104386564, was assigned on March 21, 2019. Dr. Gilmore graduated from Texas Tech University Health Sciences Center School of Medicine in 2019. Dr. Gilmore holds Florida license ME161602.

Dr. Gilmore's primary practice is Ophthalmology Surgery Center of Dallas, at 10740 North Central Expressway, Dallas, TX 75231. The practice phone is (214) 750-9288.

Dr. Gilmore's primary practice is Ophthalmology Surgery Center of Dallas in Dallas, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Gilmore to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilmore practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gilmore's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gilmore is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gilmore's licenses on file in 2 states: Florida and Texas.

Dmand AI lists eyelid inflammation, glaucoma and vision problems among the conditions Dr. Gilmore treats.

CMS data shows 87 Medicare services from Dr. Gilmore across 3 procedure codes in 2024, for 152 Medicare patients. Medicare paid $4,753 for them. Every service was in an office.

CMS counts 152 Medicare patients who saw Dr. Gilmore in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilmore's median patient age at 70, with 51% women.

In 2024, Dr. Gilmore wrote 1,946 Medicare Part D claims for 616 patients. 70% of them were for generic drugs. CMS names the drug for 1,833 of them, across 28 drugs with 11 or more claims each, at $137,668 in total drug cost. In 2023, CMS named 656 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gilmore for performance year 2024, reported as part of a group. Dr. Gilmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of cataract surgery by Dr. Gilmore, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Gilmore in 2022. Dr. Gilmore's most frequent co-authors are Kenn Alan Freedman, MD and Declan Kirk.

CMS Open Payments shows 23 general payments to Dr. Gilmore from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $715.

Dr. Gilmore graduated from Texas Tech University Health Sciences Center School of Medicine in 2019.

Dr. Gilmore is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.